{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:52:59Z","timestamp":1790286779605,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD044876"],"award-info":[{"award-number":["R01 HD044876"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG053332"],"award-info":[{"award-number":["R01AG053332"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018488","name":"Clinical and Translational Science Institute, University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016206","name":"University of California Los Angeles Clinical and Translational Science Institute","doi-asserted-by":"publisher","award":["UL1 RR024131"],"award-info":[{"award-number":["UL1 RR024131"]}],"id":[{"id":"10.13039\/100016206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.fertnstert.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T02:11:52Z","timestamp":1736907112000},"page":"1123-1132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of polycystic ovary syndrome with endothelial health, cardiovascular risk, and cellular aging"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7133-0950","authenticated-orcid":false,"given":"Ange","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Corley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni G.","family":"Jaswa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Huddleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelle I.","family":"Cedars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2025.01.006_bib1","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/diagnostics13061113","article-title":"Current guidelines for diagnosing PCOS","volume":"13","author":"Christ","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib3","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijcard.2019.02.005","article-title":"Women-specific predictors of cardiovascular disease risk \u2013 new paradigms","volume":"286","author":"Maffei","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib6","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","article-title":"2017 cardiovascular and stroke endpoint definitions for clinical trials","volume":"71","author":"Hicks","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/GME.0b013e31802cc7ab","article-title":"Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease","volume":"14","author":"Krentz","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1080\/09513590701705189","article-title":"Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15-25 years after ovarian wedge resection","volume":"23","author":"Lunde","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib10","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib12","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2017-02421","article-title":"High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam study","volume":"103","author":"Meun","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib13","first-page":"74","article-title":"Risk of cardiovascular events in patients with polycystic ovary syndrome","volume":"70","author":"Iftikhar","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1532-5415.1972.tb00787.x","article-title":"The biologic clock: the mitochondria?","volume":"20","author":"Harman","year":"1972","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nature09787","article-title":"Telomere dysfunction induces metabolic and mitochondrial compromise","volume":"470","author":"Sahin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-019-0509-4","article-title":"Polycystic ovary syndrome and mitochondrial dysfunction","volume":"17","author":"Zhang","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s43032-019-00120-6","article-title":"Telomere length and telomerase activity in immature oocytes and cumulus cells of women with polycystic ovary syndrome","volume":"27","author":"Pedroso","year":"2020","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib18","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1210\/jc.2013-3685","article-title":"A possible new mechanism in the pathophysiology of polycystic ovary syndrome (PCOS): the discovery that leukocyte telomere length is strongly associated with PCOS","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.fertnstert.2014.10.035","article-title":"Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome","volume":"103","author":"Pedroso","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10815-017-0945-z","article-title":"Significantly lengthened telomere in granulosa cells from women with polycystic ovarian syndrome (PCOS)","volume":"34","author":"Wei","year":"2017","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/bs.acc.2018.05.003","article-title":"Advances in PCOS pathogenesis and progression-mitochondrial mutations and dysfunction","volume":"86","author":"Ilie","year":"2018","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/js.2017-00192","article-title":"Insulin resistance, hyperinsulinemia, and mitochondria dysfunction in nonobese girls with polycystic ovarian syndrome","volume":"1","author":"Cree-Green","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/bmme.1997.2647","article-title":"Qualitative and quantitative changes in skeletal muscle mtDNA and expression of mitochondrial-encoded genes in the human aging process","volume":"62","author":"Barrientos","year":"1997","journal-title":"Biochem Mol Med"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib24","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1089\/dna.2019.5172","article-title":"Mitochondrial dysfunction in polycystic ovary syndrome","volume":"39","author":"Zeng","year":"2020","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib26","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3346\/jkms.2015.30.9.1213","article-title":"Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches","volume":"30","author":"Park","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib27","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.jacc.2004.08.062","article-title":"Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia","volume":"44","author":"Bonetti","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib28","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jacc.2009.10.073","article-title":"Digital assessment of endothelial function and ischemic heart disease in women","volume":"55","author":"Matsuzawa","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib29","first-page":"2167","article-title":"Assessing endothelial vasodilator function with the Endo-PAT 2000","volume":"44","author":"Axtell","year":"2010","journal-title":"J Vis Exp"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2010.07.026","article-title":"Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes","volume":"213","author":"Aragones","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","article-title":"Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction","volume":"56","author":"Borlaug","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib32","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1161\/CIRCULATIONAHA.107.748574","article-title":"Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study","volume":"117","author":"Hamburg","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib33","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/gme.0b013e31825540d8","article-title":"Depressive symptomatology, psychological stress, and ovarian reserve: a role for psychological factors in ovarian aging?","volume":"19","author":"Bleil","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib35","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1541-9215.2007.06350.x","article-title":"The Framingham risk score: an appraisal of its benefits and limitations","volume":"5","author":"Hemann","year":"2007","journal-title":"Am Heart Hosp J"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib38","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib39","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1093\/nar\/gnf067","article-title":"Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR","volume":"30","author":"He","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pnpbp.2015.06.012","article-title":"Mitochondrial DNA copy number is reduced in male combat veterans with PTSD","volume":"64","author":"Bersani","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.fertnstert.2013.08.056","article-title":"The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial","volume":"101","author":"Legro","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.fertnstert.2025.01.006_bib43","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.fertnstert.2018.08.021","article-title":"Beyond fertility: polycystic ovary syndrome and long-term health","volume":"110","author":"Cooney","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/cen.14062","article-title":"Clinical prediction score of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome (PCOS-HS index)","volume":"91","author":"Carreau","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib45","doi-asserted-by":"crossref","first-page":"e12586","DOI":"10.1111\/ijpo.12586","article-title":"Polycystic ovary syndrome in adolescent girls","volume":"15","author":"Ibanez","year":"2020","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-0035-1556568","article-title":"The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome","volume":"33","author":"Shorakae","year":"2015","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2265.2012.04490.x","article-title":"Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies","volume":"78","author":"Sprung","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib48","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.fertnstert.2010.12.011","article-title":"Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome","volume":"95","author":"Soyman","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib49","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","article-title":"Predictors of endothelial dysfunction in young women with polycystic ovary syndrome","volume":"90","author":"Kravariti","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib50","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.orcp.2009.08.001","article-title":"Endothelial function in young women with polycystic ovary syndrome (PCOS): implications of body mass index (BMI) and insulin resistance","volume":"4","author":"El-Kannishy","year":"2010","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/humrep\/dem356","article-title":"Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome","volume":"23","author":"Cascella","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib52","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/jc.2004-0751","article-title":"Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation","volume":"89","author":"Tarkun","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2265.2008.03506.x","article-title":"Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?","volume":"71","author":"Soares","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/CS20080218","article-title":"A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome","volume":"116","author":"Moran","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"Suppl A","key":"10.1016\/j.fertnstert.2025.01.006_bib55","first-page":"15A","article-title":"Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction","volume":"25","author":"Martin","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib56","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2007.11.044","article-title":"Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women","volume":"51","author":"Rossi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib57","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0735-1097(03)00333-4","article-title":"Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease","volume":"41","author":"Gokce","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib58","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.fertnstert.2022.02.028","article-title":"Subclinical cardiovascular disease and polycystic ovary syndrome","volume":"117","author":"Gomez","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib59","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1210\/jc.2014-4415","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejogrb.2022.02.020","article-title":"Morbidity and mortality in PCOS: a prospective follow-up up to a mean age above 80 years","volume":"271","author":"Forslund","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cen.14117","article-title":"The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome","volume":"92","author":"Meun","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib62","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ejendo\/lvad077","article-title":"Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study","volume":"189","author":"Ollila","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead061","article-title":"Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea\/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis","volume":"3","author":"Lo","year":"2023","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/cen.13477","article-title":"The risk of metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"88","author":"Behboudi-Gandevani","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.trsl.2013.05.004","article-title":"Telomeres and cardiovascular disease risk: an update 2013","volume":"162","author":"Nilsson","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib67","article-title":"Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome","volume":"10","author":"Gao","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib68","first-page":"3","article-title":"Polycystic ovarian syndrome and menopause in forty plus women","volume":"12","author":"Sharma","year":"2021","journal-title":"J Midlife Health"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib69","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/aogs.13489","article-title":"Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls","volume":"98","author":"Forslund","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-3623(02)00131-3","article-title":"Effect of estrogen on endothelial function and angiogenesis","volume":"38","author":"Rubanyi","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib71","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.2337\/dc21-1107","article-title":"Early menopause and cardiovascular disease risk in women with or without type 2 diabetes: a pooled analysis of 9,374 postmenopausal women","volume":"44","author":"Yoshida","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4274\/jtgga.galenos.2021.2021.0077","article-title":"An overview of polycystic ovary syndrome in aging women","volume":"22","author":"Celik","year":"2021","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.maturitas.2020.05.013","article-title":"Polycystic ovary syndrome and aging: health implications after menopause","volume":"139","author":"Helvaci","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2025.01.006_bib75","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.fertnstert.2011.09.002","article-title":"The phenotype of polycystic ovary syndrome ameliorates with aging","volume":"96","author":"Brown","year":"2011","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028225000305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028225000305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:39:48Z","timestamp":1780277988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028225000305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0015028225000305"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2025.01.006","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of polycystic ovary syndrome with endothelial health, cardiovascular risk, and cellular aging","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92025 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}